Alkermes News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.11.17	Biogen In Deal With Alkermes To Develop, Commercialize ALKS 8700 For MS (RTTNews)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
16.11.17	Alkermes Says FDA Accepts NDA Filing On ARISTADA (RTTNews)
11.11.17	ACT NOW: Monteverde & Associates PC Announces an Investigation of Alkermes plc. - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alkermes plc (ALKS) (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
27.10.17	NEOS Soars On Buyout Bid, INSY Plunges On Founder's Arrest, CELG Bleeds (RTTNews)
26.10.17	Alkermes Updates 2017 Financial Expectations - Quick Facts (RTTNews)
26.10.17	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
22.08.17	FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed (RTTNews)
21.08.17	Alkermes Initiates NDA Submission Of ALKS 5461 For Major Depressive Disorder (RTTNews)
27.07.17	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
14.07.17	Technical Reports on Drug Delivery Equities -- PetMed Express, Adamis Pharma, Delcath Systems, and Alkermes (PR Newswire)
30.06.17	CARA In Pain, ALKS Enlightened, FDA Expands Approved Use Of AMGN's Vectibix (RTTNews)
08.06.17	Alkermes Begins Supportive Study In ALKS 3831 ENLIGHTEN Development Program (RTTNews)
07.06.17	FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz (RTTNews)
06.06.17	Alkermes: FDA Approves Two-Month ARISTADA To Treat Schizophrenia - Quick Facts (RTTNews)
30.05.17	Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Adamis Pharma (PR Newswire)
25.05.17	Biotech Stocks Facing FDA Decision In June (RTTNews)
27.04.17	EARNINGS SUMMARY: Details of Alkermes plc Q1 Earnings Report (RTTNews)
18.04.17	Research Reports Initiation on Healthcare Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Amphastar Pharma (PR Newswire)
24.02.17	Healthcare Stocks on Investors' Radar -- Alkermes, Teleflex, Cascadian Therapeutics, and InspireMD (PR Newswire)
15.02.17	EARNINGS SUMMARY: Details of Alkermes plc Q4 Earnings Report (RTTNews)
13.01.17	Healthcare Stocks Under Scanner -- Valeant Pharma, Alkermes, Universal Health Services, and LifePoint Health (PR Newswire)
02.11.16	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
08.08.16	Alkermes Submits SNDA For Dosing Option Of ARISTADA To Treat Schizophrenia (RTTNews)
28.07.16	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
28.04.16	Alkermes Plans To Initiate Second Trial Of ALKS 7119 (RTTNews)
28.04.16	EARNINGS SUMMARY: Details of Alkermes plc Q1 Earnings Report (RTTNews)
31.03.16	Alkermes : Study On Naltrexone In Opioid-Dependent Patients Published (RTTNews)
25.02.16	Alkermes Announces Its Financial Expectations For 2016 - Quick Facts (RTTNews)
25.02.16	EARNINGS SUMMARY: Details of Alkermes plc Q4 Earnings Report (RTTNews)
10.02.16	Alkermes Starts Phase 3 Study Of ALKS 3831 To Evaluate Weight Gain (RTTNews)
22.01.16	AMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot (RTTNews)
21.01.16	Alkermes: Two Phase 3 Studies Of ALKS 5461 Fails To Meet Primary Endpoint (RTTNews)
29.10.15	Alkermes Announces Streamlined Registration Pathway For ALKS 8700 (RTTNews)
29.10.15	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
06.10.15	CTRV Grabs Headlines, Watch Out For EXAS Today, ONCE Gets A Spark (RTTNews)
06.10.15	Alkermes: FDA Approves ARISTADA For Treatment Of Schizophrenia (RTTNews)
30.07.15	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
30.04.15	Alkermes Q1 Loss Widens (RTTNews)
06.04.15	Alkermes Study Shows ALKS 3831's Favorable Efficacy And Mean Weight Gain Profile (RTTNews)
09.03.15	Alkermes Announces Sale Of Gainesville To Recro Pharma, Inc. - Quick Facts (RTTNews)
24.02.15	Alkermes Q4 Profit Surges - Quick Facts (RTTNews)
24.02.15	Alkermes Says Not To Pursue Further Development Of ALKS 7106 - Quick Facts (RTTNews)
23.02.15	Alkermes Names Mark Namchuk SVP Research, Pharma And Nonclinical Development (RTTNews)
09.02.15	Alkermes Reports Positive Topline Results From Phase 1 Study Of ALKS 8700 In MS (RTTNews)
07.01.15	ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Alkermes PLC

Aktien Top/Flop

Meistgelesene Nachrichten